Medtronic Announces Beacon Heart Failure Management Service, Furthering Its Commitment to Delivering Value in Healthcare
June 28 2016 - 9:00AM
New Service
Integrates Medtronic Device Data with Remote Patient Monitoring
Solutions
DUBLIN - June 28, 2016 -
Medtronic plc (NYSE:MDT) today announced availability of its Beacon
Heart Failure Management Service in the United States. This new
service from Medtronic Care Management Services (MCMS) combines
data from Medtronic implantable cardioverter defibrillator (ICD) or
cardiac resynchronization therapy (CRT) devices with post-acute
monitoring from MCMS, enabling providers to focus on heart failure
patients with the greatest risk and evaluate early intervention
before a heart failure event occurs.
"Beacon is a significant advance in our heart
failure management arsenal," said Dr. Jawwad Yusuf, cardiologist,
Advanced Heart Failure and Cardiac Transplantation, at The Stern
Cardiovascular Foundation. "With its combination of valuable device
diagnostics, day-to-day patient status and symptoms, and expert
oversight of a trained care manager, Beacon allows clinicians to
better identify, evaluate, and potentially intervene with their
high-risk heart failure patients."
Beacon integrates device diagnostics, expert
analysis, and proprietary remote monitoring solutions from MCMS to
generate an enhanced picture of a patient's health. Patients using
Beacon engage in daily health checks, which not only educate
patients about their condition and self-care, but collect symptoms
and biometrics through a series of branching-logic questions. This
data is assembled alongside diagnostics from the patient's ICD or
CRT device and reviewed by appropriately certified Medtronic care
managers. Medtronic care managers follow established clinical
pathways to review incoming data, monitor for information that
could indicate a growing risk of a heart failure event and alert
providers accordingly. Providers also receive monthly reports
summarizing the patient's health information.
"Healthcare systems are under increasing pressure
to improve patient care while also driving down associated cost.
MCMS is committed to helping our customers deliver better patient
outcomes while addressing these challenges," said Sheri Dodd, vice
president and general manager, Medtronic Care Management Services.
"Our technologies - and the data and insights they generate - put
us in a unique position to help our customers enhance their patient
care. With its combination of implanted device diagnostics, daily
monitoring, and qualified expertise, Beacon is just one way
Medtronic is innovating to provide clinically-meaningful services
to hospitals, physicians, patients, and payers."
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin,
Ireland, is among the world's largest medical technology, services
and solutions companies - alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 85,000 people worldwide, serving physicians,
hospitals and patients in approximately 160 countries. The company
is focused on collaborating with stakeholders around the world to
take healthcare Further, Together.
Any forward-looking statements
are subject to risks and uncertainties such as those described in
Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from
anticipated results.
-end-
Contacts:
Rebecca Metcalf
Public Relations
+1-763-526-9250
Ryan Weispfenning
Investor Relations
+1-763-505-4626
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Medtronic plc via Globenewswire
HUG#2023550
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024